Enhancing Utility of Neuropsychological Evaluation for Earlier and Effective Diagnosis of Dementia in Parkinson's Disease
NCT ID: NCT07114354
Last Updated: 2025-08-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
275 participants
INTERVENTIONAL
2025-08-18
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neuropsychological Assessment of Cognitive Decline in Patients With a Definite Parkinson's Disease
NCT01113242
An Observational Study for the Prevalence of Neuropsychiatric Symptom in Parkinson's Disease Dementia
NCT01102582
Development of Cognitive Assessment Tools in Parkinson Disease
NCT00556764
Dementia Registry for Parkinson's Disease
NCT01251094
Influence of Autonomy on Motor Learning in People With Parkinson's Disease
NCT05960331
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PDCogniCare
All eligible people living with Parkinson's disease who consent to participate will be registered into the PDCogniCare platform.
PDCogniCare platform
Digital platform designed to support early and accurate detection of dementia in people living with Parkinson's disease
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PDCogniCare platform
Digital platform designed to support early and accurate detection of dementia in people living with Parkinson's disease
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* People with comorbid neurological conditions (e.g. Stroke)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical Research Future Fund
OTHER
Metro South Health
OTHER
Metro North Health
UNKNOWN
Queensland University of Technology
OTHER
University of Sydney
OTHER
OPN365
UNKNOWN
Australian Dementia Network
UNKNOWN
Dementia Australia
UNKNOWN
Lions Club of Brisbane Inner North
UNKNOWN
Parkinson's Queensland
UNKNOWN
The University of Queensland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Pourzinal D, King J, Sivakumaran K, Yang J, McCann E, Mitchell LK, Brooks D, Lehn A, Liddle J, Pachana NA, Tinson H, Shrubsole K, Bailey DX, Dissanayaka NN. Evaluating evidence for a neuropsychological toolkit to predict cognitive decline in PD: A systematic review. Clin Neuropsychol. 2025 Jun 4:1-28. doi: 10.1080/13854046.2025.2511966. Online ahead of print.
Pourzinal D, Elgey C, Bailey DX, Yang J, Lehn A, Tinson H, Liddle J, Brooks D, Naismith SL, Shrubsole K, Marsh R, Mitchell LK, Pachana NA, King J, Dissanayaka NN. Diagnosis, evaluation & management of cognitive disorders in Parkinson's disease: A systematic review. Int Psychogeriatr. 2025 May 12:100081. doi: 10.1016/j.inpsyc.2025.100081. Online ahead of print.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HREC/2023/MNHA/100098
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.